INTEGRATION OF SYSTEMIC INFLAMMATION INTO DIPSS IMPROVES RISK STRATIFICATION IN MYELOFIBROSIS: DEVELOPMENT OF THE DIMOL SCORE (SIE 2026) - Oct 6, 2026 - Abstract #DP209; Pres time: Sep 22, 2026; 06:30 PM - 07:30 PM; Location: AREA POSTER; "To evaluate the prognostic impact of inflammatory in- dices in MF patients treated with ruxolitinib and to develop an inflammation-integrated prognostic model...Integration of MLR into the DiMoL score refines risk stratification and identifies more homogeneous prognos- tic subgroups than DIPSS alone. These findings support the incorporation of simple inflammatory biomarkers into clini- cal practice and provide a rationale for prospective studies evaluating inflammation-targeted strategies in MF."
Fibrosis • Hematological Disorders • Immunology • Inflammation • Myelofibrosis • Systemic Inflammatory Response Syndrome • CALR
|
|
A. Votto1; A. Duminuco2; G. Lavenia3; A. Brunetti1; M. Maggiorelli1; G. A. Palumbo2; S. Galimberti1
|